You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › March › 10
CagriSema
16 months ago
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug ○
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug ○
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
page 1 of 1